Recent Finacing
Recent Raise
OctreoPharm Sciences GmbH develops radiopharmaceutical diagnostics and therapeutics for neuroendocrine tumors, advancing its lead SOMscan agent through clinical development for tumor detection and treatment monitoring.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors